(Q37216076)

English

Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up

scientific article published on 28 August 2013

Statements

Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up (English)
Sander F Rodrigo
Jan van Ramshorst
Georgette E Hoogslag
Matthijs A Velders
Suzanne C Cannegieter
Petra Dibbets-Schneider
Willem E Fibbe
Jaap Jan Zwaginga
Saskia L Beeres

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit